Office For Life Sciences
Details
The Life Sciences Innovative Manufacturing Fund (LSIMF) is part of the Global Britain Investment Fund and will provide 60 million in capital grants for investment in the manufacture of:
- human medicines (drug substance and drug product)
- medical diagnostics
- MedTech products
We have already announced the first tranche of companies to be supported by LSIMF and are now re-opening the fund with the remaining budget of 7.6 million.
Specific themes
We particularly welcome applications from companies with manufacturing investments that demonstrate the adoption of innovative process technologies, for example:
- flexible manufacturingenabling rapid product switching
- continuous manufacturing
- technologies that willminimise impact of the product or the manufacturing process on the environment
- digital twins, which harness the power of data analytics and modelling to optimise manufacturing processes
This list is not exhaustive.
Eligibility
This is a summary of the minimum requirements for in scope projects (read the scheme guidance for full details):
| Your manufacturing investment must relate to the manufacture of: | Human medicines (this includes both the manufacture of active pharmaceutical ingredients (API) / drug substance and finished product / drug product). The fund is open to applications across the breadth of types of MHRA licenced medicines for human use, OR Diagnostics for both disease identification and monitoring in human health, OR Medical devices all types of medical devices related to human health We will not accept applications that propose to manufacture: - veterinary medicines - herbal supplements and vitamins - input materials - consumables or equipment suppliers (for example vials, syringes) |
|---|---|
| Your project must: | Be a manufacturing project: this could be manufacturing product for clinical trials or for commercial sale, AND Be located in the UK, AND Have a total investment value of more than 20 million |
| You will be required to: | Demonstrate that your company has the financial capacity to deliver the project; AND Demonstrate that the project is fully funded aside from the grant request; AND Provide 3 years of annual audited accounts |
| To protect public funding, you must: | Provide a parental undertaking guarantee from your ultimate parent company; OR Secure and pay for a bank guarantee for the full grant amount over the duration of the project |
Fund objectives
We will prioritise applicants based on their alignment to the funds objectives:
1.Creating economic opportunity through investments that will provide high-wage, high-skilled jobs.
2.Deploying cutting-edge innovations (at both pilot and commercial scale) which can be embedded in either the product itself or the manufacturing process.
3.Increasing health resilience, either through increased domestic capacity or by providing flexible capabilities that can be re-deployed in some way in a future health emergency.
4.Minimising impact on the environment, which might include reduction in input resources or using alternative input materials to become more sustainable or support the governments net zero target.
How to apply
1. If your company and project meet ALL the criteria listed above and you confirm you will be able to provide the required evidence and financial guarantees - submit a short summary of your project (no longer than one side of A4) outlining:
- project background: a description of the planned investment, relevant context and an indication of when the investme